The Sealy Center for Vaccine ScopeDevelopment (SCVD) fosters the highest quality collaborative and programmatic research and facilitates the translation of laboratory findings to prevention of infectious diseases in the community.

The University of Texas Medical Branch's (UTMB's) area of expertise is focused on, but not limited to, emerging and infectious diseases. Examples of diseases and pathogens for which vaccine development research and/or clinical trials are being conducted include: parasitic diseases (malaria, cutaneous and visceral leishmaniases and Trypanosoma cruzi), respiratory diseases (including anthrax, tuberculosis, influenza and respiratory syncytial virus), arboviruses (including Chikungunya, dengue and West Nile), sexually transmitted diseases (including genital herpes and papillomavirus), rickettsia, hemorrhagic fevers (such as Argentine hemorrhagic fever, Crimean-Congo hemorrhagic fever, Lassa fever, Ebola, Marburg, and Rift Valley fever), and enteric bacteria (such as Helicobacter pylori and Eacherichia coli).

The center currently collaborates with UTMB's Center for Addiction Research and the George P. and Cynthia Woods Mitchell Center for Neurodegenerative Diseases to foster development of vaccines for prevention and treatment of chronic non-infectious diseases such as cancer, cocaine addiction and Alzheimer's disease.